|
|
||||||||
From the Divisions of Immunology and Virology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, England
Abstract
We have tested the two principal theories which explain the previous finding that small amounts of type-specific antibody to the adenovirus hexon can neutralize infectivity, whereas even large amounts of cross-reactive antibody do not.
We conclude that the mechanism of neutralization by antibody is complicated, and that the type-specific determinants exposed on the virion must play a crucial role.
Footnotes
1 Present address: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
This article has been cited by other articles:
![]() |
B. Lin, G. J. Vora, D. Thach, E. Walter, D. Metzgar, C. Tibbetts, and D. A. Stenger Use of Oligonucleotide Microarrays for Rapid Detection and Serotyping of Acute Respiratory Disease-Associated Adenoviruses J. Clin. Microbiol., July 1, 2004; 42(7): 3232 - 3239. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Soudais, S. Boutin, S. S. Hong, M. Chillon, O. Danos, J. M. Bergelson, P. Boulanger, and E. J. Kremer Canine Adenovirus Type 2 Attachment and Internalization: Coxsackievirus-Adenovirus Receptor, Alternative Receptors, and an RGD-Independent Pathway J. Virol., November 15, 2000; 74(22): 10639 - 10649. [Abstract] [Full Text] |
||||
![]() |
J. G. D. Gall, R. G. Crystal, and E. Falck-Pedersen Construction and Characterization of Hexon-Chimeric Adenoviruses: Specification of Adenovirus Serotype J. Virol., December 1, 1998; 72(12): 10260 - 10264. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |